These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9433170)

  • 21. [Botulinum toxin treatment -- state of the art 2000].
    Auff E; Poewe W; Schnider P; Wissel J
    Wien Klin Wochenschr; 2001; 113 Suppl 4():1. PubMed ID: 15506043
    [No Abstract]   [Full Text] [Related]  

  • 22. Botulinum toxin type A therapy for chronic tension-type headache: fact versus fiction.
    Gupta VK
    Pain; 2005 Jul; 116(1-2):166-7; author reply 167. PubMed ID: 15927392
    [No Abstract]   [Full Text] [Related]  

  • 23. Botulinum toxin type A in the treatment of sialorrhea in Parkinson's disease.
    Melo A; Rodrigues B; Nóbrega AC
    J Am Geriatr Soc; 2009 Jan; 57(1):180; author reply 180-1. PubMed ID: 19170803
    [No Abstract]   [Full Text] [Related]  

  • 24. Botulinum toxin a treatment in chronic daily headache.
    Cutrer FM
    Headache; 2005 Apr; 45(4):270-1. PubMed ID: 15836560
    [No Abstract]   [Full Text] [Related]  

  • 25. [Criteria and best clinical practice guidelines for first intradetrusor injection of botulinum toxin type A to treat neurogenic detrusor overactivity].
    Perrouin-Verbe B; Ruffion A; Gamé X; Denys P; Kerdraon J; Karsenty G; de Sèze M; Haab F; Saussine C; Soler JM; Amarenco G; Chartier-Kastler E
    Prog Urol; 2009 Jun; 19(6):372-82. PubMed ID: 19467455
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Botulinum toxin type A for the treatment of headache: why we say yes.
    Ashkenazi A; Silberstein S
    Arch Neurol; 2008 Jan; 65(1):146-9. PubMed ID: 18195155
    [No Abstract]   [Full Text] [Related]  

  • 27. [Botulinum toxin as a treatment for strabismus in systemic diseases].
    Moguel-Ancheita S; Dixon-Olvera S; Martínez-Oropeza S; Orozco-Gómez LP
    Arch Soc Esp Oftalmol; 2003 Jan; 78(1):9-14. PubMed ID: 12571768
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The use of botulinum toxin A in perioral rejuvenation.
    Kaplan SE; Sherris DA; Gassner HG; Friedman O
    Facial Plast Surg Clin North Am; 2007 Nov; 15(4):415-21, v-vi. PubMed ID: 18005882
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Why do children with cerebral palsy discontinue therapy with botulinum toxin A?
    Weigl DM; Arbel N
    Dev Med Child Neurol; 2007 Feb; 49(2):159-60. PubMed ID: 17297747
    [No Abstract]   [Full Text] [Related]  

  • 30. Use of botulinum toxin type A in children with cerebral palsy.
    Nolan KW; Cole LL; Liptak GS
    Phys Ther; 2006 Apr; 86(4):573-84. PubMed ID: 16579673
    [No Abstract]   [Full Text] [Related]  

  • 31. Botulinum toxin type A therapy in a patient with cervical dystonia and amyotrophic lateral sclerosis.
    Singer C; Papapetropaulos S; Ayyar DR; Verma A
    Mov Disord; 2007 Jan; 22(2):289. PubMed ID: 17094101
    [No Abstract]   [Full Text] [Related]  

  • 32. The place of botulinum toxin type A in the treatment of focal hyperhidrosis.
    Benohanian A
    Br J Dermatol; 2005 Aug; 153(2):460-1; author reply 461. PubMed ID: 16086777
    [No Abstract]   [Full Text] [Related]  

  • 33. Worldwide experience with botulinum toxin type A.
    Karsenti G
    J Cosmet Laser Ther; 2003 Dec; 5(3-4):208-9. PubMed ID: 14741833
    [No Abstract]   [Full Text] [Related]  

  • 34. The use of botulinum toxin-A in the treatment of patients with fibromyalgia.
    Asherson RA; Pascoe L
    J Rheumatol; 2001 Jul; 28(7):1740. PubMed ID: 11469493
    [No Abstract]   [Full Text] [Related]  

  • 35. Botulinum toxin in primary care medicine.
    Felber ES
    J Am Osteopath Assoc; 2006 Oct; 106(10):609-14. PubMed ID: 17122031
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 'Why do children with cerebral palsy discontinue therapy with botulinum toxin A?'.
    Linder-Lucht M; Kirschner J; Herrmann J; Geth K; Korinthenberg R; Berweck S; Heinen F; Mall V
    Dev Med Child Neurol; 2006 Apr; 48(4):319-20. PubMed ID: 16542523
    [No Abstract]   [Full Text] [Related]  

  • 37. Dynamic polyelectromyography, neurolysis, and chemodenervation with botulinum toxin A for assessment and treatment of gait dysfunction.
    Esquenazi A; Mayer NH; Keenan MA
    Adv Neurol; 2001; 87():321-31. PubMed ID: 11347237
    [No Abstract]   [Full Text] [Related]  

  • 38. Botulinum toxin therapy for palmar hyperhidrosis: experience in an Iranian population.
    Aghaei S
    Int J Dermatol; 2007 Feb; 46(2):212-4. PubMed ID: 17269981
    [No Abstract]   [Full Text] [Related]  

  • 39. Treatment of globus by upper esophageal sphincter injection with botulinum A toxin.
    Halum SL; Butler SG; Koufman JA; Postma GN
    Ear Nose Throat J; 2005 Feb; 84(2):74. PubMed ID: 15794538
    [No Abstract]   [Full Text] [Related]  

  • 40. Ranula successfully treated by botulinum toxin type A: report of 3 cases.
    Chow TL; Chan SW; Lam SH
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Jan; 105(1):41-2. PubMed ID: 17764989
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.